Independent drug action in combination therapy: implications for precision oncology
Combination therapies are superior to monotherapy for many cancers. This advantage was
historically ascribed to the ability of combinations to address tumor heterogeneity, but …
historically ascribed to the ability of combinations to address tumor heterogeneity, but …
Independent Drug Action in Combination Therapy: Implications for Precision Oncology
D Plana, AC Palmer, PK Sorger - Cancer discovery, 2022 - pubmed.ncbi.nlm.nih.gov
Combination therapies are superior to monotherapy for many cancers. This advantage was
historically ascribed to the ability of combinations to address tumor heterogeneity, but …
historically ascribed to the ability of combinations to address tumor heterogeneity, but …
[PDF][PDF] Independent Drug Action in Combination Therapy: Implications for Precision Oncology
D Plana, AC Palmer, PK Sorger - Cancer Discovery, 2022 - AACR
Combination therapies are superior to monotherapy for many cancers. This advantage was
historically ascribed to the ability of combinations to address tumor heterogeneity, but …
historically ascribed to the ability of combinations to address tumor heterogeneity, but …
[HTML][HTML] Independent Drug Action in Combination Therapy: Implications for Precision Oncology
D Plana, AC Palmer, PK Sorger - Cancer Discovery, 2022 - ncbi.nlm.nih.gov
Combination therapies are superior to monotherapy for many cancers. This advantage was
historically ascribed to the ability of combinations to address tumor heterogeneity, but …
historically ascribed to the ability of combinations to address tumor heterogeneity, but …
Independent Drug Action in Combination Therapy: Implications for Precision Oncology.
D Plana, AC Palmer, PK Sorger - Cancer Discovery, 2022 - europepmc.org
Combination therapies are superior to monotherapy for many cancers. This advantage was
historically ascribed to the ability of combinations to address tumor heterogeneity, but …
historically ascribed to the ability of combinations to address tumor heterogeneity, but …
[PDF][PDF] Independent Drug Action in Combination Therapy: Implications for Precision Oncology
D Plana, AC Palmer, PK Sorger - networks, 2022 - ccsp.hms.harvard.edu
Combination therapies are superior to monotherapy for many cancers. This advantage was
historically ascribed to the ability of combinations to address tumor heterogeneity, but …
historically ascribed to the ability of combinations to address tumor heterogeneity, but …
[HTML][HTML] Independent Drug Action in Combination Therapy: Implications for Precision Oncology
D Plana, AC Palmer, PK Sorger - Cancer discovery, 2022 - ncbi.nlm.nih.gov
Combination therapies are superior to monotherapy for many cancers. This advantage was
historically ascribed to the ability of combinations to address tumor heterogeneity, but …
historically ascribed to the ability of combinations to address tumor heterogeneity, but …